DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
You are receiving this because you have an account on www.oneGRAVESvoice.com | ||
To unsubscribe from these emails, click here |
Trusted Resources: News & Meetings
Latest announcements and gatherings
Prevent Blindness Art Therapy Program
Prevent Blindness is excited to announce the launch of the first ever art therapy program for people with Thyroid Eye Disease and their care partners. The Prevent Blindness Art Therapy Program participants will:
• Partake in eight weekly 90-minute in-person or virtual sessions to create art using a variety of artistic media.
• Explore art therapy as a way to cope with feelings of isolation, anxiety and depression.
• Discover an opportunity to build community and connections with other people who are affected by Thyroid Eye Disease (TED) and express thoughts and feelings through art.
• Interact with registered art therapists who will tailor the program topics, themes and materials for people affected by TED.
Who Is Eligible to Apply?
Individuals with thyroid eye disease and their care partners (spouses, family members, friends, loved ones).
When:
April 02, 2022
This event has ended.
Related Content
-
Community CenterDiagnosed With Graves’ Disease Then Thyroid Cancer – LorrieA patient’s thyroid cancer story about...
-
News & MeetingsMeeting of Dermatologic and Ophthalmic Drugs Advisory Committee AnnouncementThe committee will discuss biologics lic...
-
Evidence & EducationRelation Between Therapy for Hyperthyroidism and the Course of Graves’ OphthalmopathyBackground: The chief clinical characte...
-
Evidence & EducationThe Efficacy of Rituximab Combined with 131I for Ophthalmic Outcomes of Graves’ Ophthalmopathy PatientsPurpose: The purpose of this study is t...
-
News & MeetingsNew York Walk & Public ForumWe walk to raise awareness, and to honor...
-
Evidence & EducationHyperthyroid Patients Without Graves’ Orbitopathy are not at Increased Risk of Developing Glaucoma: A Nationwi...Purpose: Graves' disease (GD) and toxic...
-
Videos & VisualsGraves’ Disease: What Were Your Symptoms?https://www.youtube.com/watch?v=0WrxPDQV...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.